{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:08:58Z","timestamp":1793304538489,"version":"4.5.0"},"reference-count":20,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,10,1]]},"abstract":"\n OBJECTIVE:<\/jats:title>\n To document the patterns of bilirubin and hematocrit values among glucose-6-phosphate dehydrogenase (G6PD)-deficient and G6PD-normal Nigerian neonates in the first week of life, in the absence of exposure to known icterogenic agents.<\/jats:p>\n <\/jats:sec>\n \n METHODS:<\/jats:title>\n The G6PD status of consecutive term and near-term neonates was determined, and their bilirubin levels and hematocrits were monitored during the first week of life. Infants were stratified into G6PD deficient, intermediate, and normal on the basis of the modified Beutler\u2019s fluorescent spot test. Means of total serum bilirubin (TSB) and hematocrits of the 3 groups of infants were compared.<\/jats:p>\n <\/jats:sec>\n \n RESULTS:<\/jats:title>\n The 644 neonates studied comprised 353 (54.8%) boys and 291 (45.2%) girls and 540 (83.9%) term and 104 (16.1%) near-term infants. They consisted of 129 (20.0%) G6PD-deficient, 69 (10.7%) G6PD-intermediate, and 446 (69.3%) G6PD-normal neonates. The G6PD-deficient and G6PD-intermediate infants had higher mean TSB than their G6PD-normal counterparts at birth and throughout the first week of life (P &lt; .001). Mean peak TSB levels were 14.1 (9.48), 10.2 (3.8), and 6.9 (3.3) mg\/dL for G6PD-deficient, G6PD-intermediate, and G6PD-normal neonates, respectively. Peak TSB was attained on approximately day 4 in all 3 groups, and trends in TSB were similar. Mean hematocrits at birth were similar in the 3 G6PD groups. However, G6PD-deficient and -intermediate infants had higher declines in hematocrit, bilirubin levels, and need for phototherapy than G6PD-normal infants (P &lt; .001).<\/jats:p>\n <\/jats:sec>\n \n CONCLUSIONS:<\/jats:title>\n The G6PD-deficient and G6PD-intermediate neonates had a higher risk of neonatal hyperbilirubinemia and would therefore need greater monitoring in the first week of life, even without exposure to known icterogenic agents.<\/jats:p>\n <\/jats:sec>","DOI":"10.1542\/peds.2014-0654","type":"journal-article","created":{"date-parts":[[2014,9,23]],"date-time":"2014-09-23T04:29:08Z","timestamp":1411446548000},"page":"e1082-e1088","source":"Crossref","is-referenced-by-count":16,"title":["Early Neonatal Bilirubin, Hematocrit, and Glucose-6-Phosphate Dehydrogenase Status"],"prefix":"10.1542","volume":"134","author":[{"given":"Bolaji O.","family":"Badejoko","sequence":"first","affiliation":[{"name":"Departments of Paediatrics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A.","family":"Owa","sequence":"additional","affiliation":[{"name":"Departments of Paediatrics,"},{"name":"Departments of Paediatrics and Child Health,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saheed B.A.","family":"Oseni","sequence":"additional","affiliation":[{"name":"Departments of Paediatrics,"},{"name":"Departments of Paediatrics and Child Health,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olusegun","family":"Badejoko","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynaecology and Perinatology, and"},{"name":"Obstetrics and Gynaecology and Perinatology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adesegun O.","family":"Fatusi","sequence":"additional","affiliation":[{"name":"Community Health, Obafemi Awolowo University, Ile-Ife, Nigeria"},{"name":"Community Health, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Nigeria; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebunoluwa A.","family":"Adejuyigbe","sequence":"additional","affiliation":[{"name":"Departments of Paediatrics,"},{"name":"Departments of Paediatrics and Child Health,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2014,10,1]]},"reference":[{"issue":"4","key":"2021120906532042800_B1","first-page":"354","article-title":"The incidence and outcome of bilirubin encephalopathy in Nigeria: a bi-centre study.","volume":"16","author":"Ogunlesi","year":"2007","journal-title":"Niger J Med"},{"key":"2021120906532042800_B2","first-page":"23","article-title":"Neonatal Jaundice at Wesley Guild Hospital, Ilesa and Ife State Hospital, Ile-Ife.","volume":"16(1&2)","author":"Owa","year":"1989","journal-title":"Niger J Paediatr"},{"key":"2021120906532042800_B3","first-page":"11","article-title":"Kernicterus in Nigerian infants.","volume":"6","author":"Owa","year":"1987","journal-title":"West Afr J Med"},{"issue":"1","key":"2021120906532042800_B4","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0022-3476(95)70510-4","article-title":"Glucose-6-phosphate dehydrogenase deficiency and carboxyhemoglobin concentrations associated with bilirubin-related morbidity and death in Nigerian infants.","volume":"126","author":"Slusher","year":"1995","journal-title":"J Pediatr"},{"issue":"6","key":"2021120906532042800_B5","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1651-2227.1989.tb11162.x","article-title":"Relationship between exposure to icterogenic agents, glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice in Nigeria.","volume":"78","author":"Owa","year":"1989","journal-title":"Acta Paediatr Scand"},{"key":"2021120906532042800_B6","first-page":"47","article-title":"Influence of glucose-6-phosphate dehydrogenase status on bilirubin and hematocrit in healthy Nigerian neonates.","volume":"22","author":"Owa","year":"1991","journal-title":"Niger Med Pract"},{"issue":"1","key":"2021120906532042800_B7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1053\/j.semperi.2006.01.007","article-title":"A recommendation for the definition of \u201clate preterm\u201d (near-term) and the birth weight-gestational age classification system.","volume":"30","author":"Engle","year":"2006","journal-title":"Semin Perinatol"},{"issue":"3","key":"2021120906532042800_B8","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0022-3476(05)82056-6","article-title":"New Ballard Score, expanded to include extremely premature infants.","volume":"119","author":"Ballard","year":"1991","journal-title":"J Pediatr"},{"issue":"5","key":"2021120906532042800_B9","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1182\/blood.V32.5.816.816","article-title":"Special modifications of the fluorescent screening method for glucose-6-phosphate dehydrogenase deficiency.","volume":"32","author":"Beutler","year":"1968","journal-title":"Blood"},{"key":"2021120906532042800_B10"},{"issue":"4","key":"2021120906532042800_B11","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1542\/peds.2009-0329","article-title":"Hyperbilirubinemia in the newborn infant > or =35 weeks\u2019 gestation: an update with clarifications.","volume":"124","author":"Maisels","year":"2009","journal-title":"Pediatrics"},{"issue":"3","key":"2021120906532042800_B12","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.bcmd.2008.12.005","article-title":"The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis.","volume":"42","author":"Nkhoma","year":"2009","journal-title":"Blood Cells Mol Dis"},{"issue":"3","key":"2021120906532042800_B13","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1651-2227.1980.tb07090.x","article-title":"The risk of jaundice in glucose-6-phosphate dehydrogenase deficient babies exposed to menthol.","volume":"69","author":"Olowe","year":"1980","journal-title":"Acta Paediatr Scand"},{"issue":"2","key":"2021120906532042800_B14","doi-asserted-by":"crossref","DOI":"10.1542\/peds.114.2.e213","article-title":"Hyperbilirubinemia among African American, glucose-6-phosphate dehydrogenase-deficient neonates.","volume":"114","author":"Kaplan","year":"2004","journal-title":"Pediatrics"},{"issue":"2","key":"2021120906532042800_B15","doi-asserted-by":"crossref","first-page":"F123","DOI":"10.1136\/adc.2004.058313","article-title":"Neonatal bilirubin production-conjugation imbalance: effect of glucose-6-phosphate dehydrogenase deficiency and borderline prematurity.","volume":"90","author":"Kaplan","year":"2005","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"1","key":"2021120906532042800_B16","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1203\/PDR.0b013e31815b8e7e","article-title":"(TA)n UDP-glucuronosyltransferase 1A1 promoter polymorphism in Nigerian neonates.","volume":"63","author":"Kaplan","year":"2008","journal-title":"Pediatr Res"},{"issue":"3","key":"2021120906532042800_B17","doi-asserted-by":"crossref","DOI":"10.1542\/peds.102.3.e37","article-title":"Bilirubin conjugation, reflected by conjugated bilirubin fractions, in glucose-6-phosphate dehydrogenase-deficient neonates: a determining factor in the pathogenesis of hyperbilirubinemia.","volume":"102","author":"Kaplan","year":"1998","journal-title":"Pediatrics"},{"key":"2021120906532042800_B18"},{"issue":"2","key":"2021120906532042800_B19","first-page":"243","article-title":"Human glucose-6-phosphate dehydrogenase variants.","volume":"45","author":"Yoshida","year":"1971","journal-title":"Bull World Health Organ"},{"issue":"1","key":"2021120906532042800_B20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1542\/peds.114.1.297","article-title":"Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation.","volume":"114","author":"American Academy of Pediatrics Subcommittee on Hyperbilirubinemia","year":"2004","journal-title":"Pediatrics"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/134\/4\/e1082\/1100134\/peds_2014-0654.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/134\/4\/e1082\/1100134\/peds_2014-0654.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T01:13:02Z","timestamp":1639098782000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/134\/4\/e1082\/33008\/Early-Neonatal-Bilirubin-Hematocrit-and-Glucose-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,1]]},"references-count":20,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,10,1]]},"published-print":{"date-parts":[[2014,10,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2014-0654","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,1]]}}}